Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes
- PMID: 20117688
- DOI: 10.1016/j.apnu.2009.04.009
Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes
Abstract
Objective: The aim of this article is to present a current discussion related to the nursing care of clients treated with atypical antipsychotic medicines and who have a risk of developing metabolic instability and/or Type 2 diabetes. The importance of such a discussion is to provide both the novice and the experienced nurse with additional knowledge of this current health issue with which to inform their nursing practice.
Discussion: The potential for psychosis to be a chronic condition is very high, and often people require antipsychotic medicine for lengthy periods throughout their lives. Sometimes, treatment is for life. The second generation of antipsychotic medicines was greeted with much enthusiasm since it was better tolerated than the first generation. However, each medication has desired and adverse effects and, when taken for lengthy periods, these effects may produce physical illness. Studies show that the prevalence of Type 2 diabetes and the metabolic syndrome was significantly higher in clients with a chronic psychiatric disorder, particularly schizophrenia.
Conclusions: Metabolic instability, especially weight gain, is associated with some psychotropic medicines. Nursing interventions need to include care assessment, planning, intervention, and evaluation for clients treated with antipsychotic medicines in terms of risk minimization strategies in routine nursing care.
2010 Elsevier Inc. All rights reserved.
Similar articles
-
Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.Int J Ment Health Nurs. 2011 Dec;20(6):428-37. doi: 10.1111/j.1447-0349.2011.00747.x. Epub 2011 May 12. Int J Ment Health Nurs. 2011. PMID: 21564457
-
Which comes first: atypical antipsychotic treatment or cardiometabolic risk?Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x. Acta Psychiatr Scand. 2009. PMID: 19178394 Review.
-
Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.J Clin Psychiatry. 2001;62 Suppl 27:35-9; discussion 40-1. J Clin Psychiatry. 2001. PMID: 11806488
-
Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.Ann Pharmacother. 2007 Oct;41(10):1593-603. doi: 10.1345/aph.1K141. Epub 2007 Sep 4. Ann Pharmacother. 2007. PMID: 17785613 Review.
-
Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.Pharmacotherapy. 2009 Aug;29(8):975-87. doi: 10.1592/phco.29.8.975. Pharmacotherapy. 2009. PMID: 19637951
Cited by
-
Mental Health Nurses Attitudes and Practice Toward Physical Health Care in Jordan.Community Ment Health J. 2017 Aug;53(6):725-735. doi: 10.1007/s10597-017-0143-6. Epub 2017 May 9. Community Ment Health J. 2017. PMID: 28488111
-
Beliefs about health, health risks and health expectations from the perspective of people with a psychotic disorder.Open Nurs J. 2013 Aug 20;7:114-22. doi: 10.2174/1874434601307010114. eCollection 2013. Open Nurs J. 2013. PMID: 24039643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical